Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.

Evelyn K. Holmer

Evelyn Holmer represents clients in corporate law matters, including private placements, equity financing transactions, general corporate law, and mergers and acquisitions.

Evelyn has significant experience in representing both investors and biotechnology growth entities in equity financings and dispositions, with particular expertise in the biopharma, technology, and medical device industries. Her experience includes joint ventures, private placements, securities offerings, and venture capital transactions.

In the area of private equity and venture capital funds, Evelyn advises clients on a gamut of issues, including organization and formation, the fundraising process, governance matters, and investments in portfolio companies.

Evelyn has broad experience in structuring and closing a myriad of early-stage and growth-stage capital formation transactions, including technology transfer, seed investment, early-stage investment, and follow-on preferred investment transactions.

Ranked in the “Up and Coming” category in Chambers USA 2019 in Ohio Corporate/M&A, Evelyn is described as “proactive, responsive and with great technical expertise.”

Evelyn lives in Cleveland with her husband. In her spare time, she enjoys traveling and managing her dogs’ Instagram careers.

Cleveland-Marshall College of Law (J.D., summa cum laude, 2006); Co-Editor in Chief, Journal of Law and Health (2005-2006)
Emerson College (B.S., cum laude, 1999)
State Admissions
Ohio, 2006
  • Represented multiple biotech funds in their formation, securities offerings, and portfolio acquisitions
  • Represented a private issuer in private placement and securities matters that raised close to $200 million (preferred securities, convertible note instruments) for ventures related to early-stage pharmaceutical assets
  • Represented a family office investor in a series of preferred stock and debt investments in companies focused on biotechnology assets
  • Represented a company in the pharmaceutical industry in corporate matters since formation and several private placements of LLC preferred equity units and convertible debt with total capital raised of approximately $35 million
  • Represented a biotechnology company in its merger with and into a public company in a transaction valued at approximately $12 million

speaking engagements

  • “Starting Your Life Sciences Company,” CSSI Life Sciences, LifeX Labs Accelerator (April 2020)
  • Chambers USA
    • “Up and Coming” in Corporate/M&A (Ohio) (2016-2019)
  • The Best Lawyers in America® (2020-2022)
  • Ohio Super Lawyers Rising Stars® (2015, 2016)
  • Cleveland Metropolitan Bar Association
  • Greater Cleveland Sports Commission, Associate Board